tirzepatide and hormone replacement therapy FDA approval for Zepbound (tirzepatide) injection, the first only obesity treatment of its kind that activates both GIP and GLP-1 receptors - Eli Lilly Hormone Therapy Boosts Weight-Loss Effects

Moreover, there is emerging evidence that omega-3 fatty acids may modulate the gut microbiota, which plays a pivotal role in metabolic health and liver diseases

It also showed an increase in insulin resistance

Impact of nutrition support on treatment outcome in patients with locally advanced head and neck squamous cell cancer treated with definitive radiotherapy: a secondary analysis of RTOG trial 90-03

Conclusion Weight alters your fertility odds

Semaglutide 2.4 mg reduced the rate of major adverse cardiovascular events (MACE: cardiovascular death, nonfatal myocardial infarction, nonfatal stroke) by 20% compared to placebo (HR 0.80

Zhang T, Zhu X, Wu H, Jiang K, Zhao G, Shaukat A, et al